SCHEMBL7511997

SCHEMBL7511997

COc1cc(CO)cc(OC)c1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.58
GAA P10253 2/20 0.53
MGAM O43451 1/20 0.53
SI P14410 1/20 0.53
MGAM2 Q2M2H8 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
BLM P54132 1/20 0.52
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
HTR1A P08908 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231635 0.90 ALDH1A1 (0.64) HSD17B10GAAMGAMSIMGAM2
SCHEMBL4420078 0.88 LIPE (0.47) HSD17B10MAPTMAPK1SMN1; SMN2L3MBTL1
SCHEMBL3457611 0.87 CYP4F2 (0.54) HSD17B10GAAMGAMSIMGAM2
SCHEMBL28108814 0.87 ABCB1 (0.50) HSD17B10GAAMGAMSIMGAM2
SCHEMBL6972762 0.84 MEN1 (0.50) GAAMGAMSIMGAM2MEN1
SCHEMBL27998563 0.83 MAOB (0.59) GAAMGAMSIMGAM2MEN1
SCHEMBL12431888 0.83 HTR1A (0.50) GAAMGAMSIMGAM2MEN1
SCHEMBL10925538 0.83 HTR1A (0.50) GAAMGAMSIMGAM2MEN1
SCHEMBL19738025 0.82 GAA (0.47) HSD17B10GAAMGAMSIMGAM2
SCHEMBL698056 0.82 NPC1 (0.63) HSD17B10MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287226-B2 Mild catalytic reduction of C—O bonds and C═O bonds using a recyclable catalyst system ORGANOFUEL SWEDEN AB (SE) 2019-05-14 US disclosed
US-20170334819-A1 A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM ORGANOFUEL SWEDEN AB (SE) 2017-11-23 US disclosed
WO-2002074300-A1 COMPOSITION FOR TREATING ARTERIOSCLEROSIS COMPRISING 3-(4'-HYDROXYL-3',5'-DIMETHOXYPHENYL)PROPIONIC ACID OR ITS DERIVATIVES DONG WHA PHARM. IND. CO., LTD. (KR) 2002-09-26 WO disclosed
WO-2001014331-A2 NON-QUINOLINE INHIBITORS OF MALARIA PARASITES REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334819-A1 A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM CBR1, ADH1C, AOC2 HSD17B10 549/4885GAA 1025/4885MGAM 220/4885
US-10287226-B2 Mild catalytic reduction of C—O bonds and C═O bonds using a recyclable catalyst system CBR1, ADH1C, CBR3 HSD17B10 570/4885GAA 1047/4885MGAM 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.